About this FactMed analysis covering adverse side effect reports of AGGRENOX patients who developed BRONCHITIS.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 29 individuals taking AGGRENOX reported BRONCHITIS to the FDA. A total of 3940 AGGRENOX drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AGGRENOX and BRONCHITIS. In doing so, we compare AGGRENOX with other drugs that cause BRONCHITIS, to help you evaluate whether or not AGGRENOX causes BRONCHITIS. Likewise, this page shows the most highly-reported side effects of AGGRENOX, so you can see if BRONCHITIS ranks among AGGRENOX's most well-known side effects.
Summary Statistics
Reports of AGGRENOX causing BRONCHITIS: 29
Reports of any side effect of AGGRENOX : 3940
Percentage of AGGRENOX patients where BRONCHITIS is a reported side effect: 0.7360%

FDA reports of any drug causing BRONCHITIS : 21681
Average percentage for all medicated patients where BRONCHITIS is reported as a complication: 0.1359%

Physician opinion on AGGRENOX as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AGGRENOX:
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 573 patients )
TRANSIENT ISCHAEMIC ATTACK ( 426 patients )
CEREBROVASCULAR ACCIDENT ( 325 patients )
PROPHYLAXIS ( 114 patients )
DRUG USE FOR UNKNOWN INDICATION ( 81 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 80 patients )
ANTICOAGULANT THERAPY ( 71 patients )
THROMBOSIS PROPHYLAXIS ( 25 patients )
ANTIPLATELET THERAPY ( 24 patients )
ISCHAEMIC STROKE ( 14 patients )
CAROTID ARTERY OCCLUSION ( 14 patients )
HYPERTENSION ( 12 patients )
ISCHAEMIC CEREBRAL INFARCTION ( 11 patients )
ATRIAL FIBRILLATION ( 11 patients )
CORONARY ARTERY DISEASE ( 9 patients )
CEREBRAL INFARCTION ( 7 patients )
VASCULAR SHUNT ( 7 patients )
ARTERIAL DISORDER ( 7 patients )
THROMBOSIS ( 7 patients )
LACUNAR INFARCTION ( 6 patients )
CARDIAC DISORDER ( 5 patients )
PLATELET AGGREGATION ABNORMAL ( 5 patients )
ANGIOPATHY ( 5 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 5 patients )
CEREBRAL ISCHAEMIA ( 5 patients )
CEREBROVASCULAR DISORDER ( 4 patients )
CARDIOVASCULAR DISORDER ( 4 patients )
CEREBROVASCULAR INSUFFICIENCY ( 4 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 4 patients )
CAROTID ARTERY STENOSIS ( 3 patients )
HYPERHOMOCYSTEINAEMIA ( 3 patients )
HYPOAESTHESIA FACIAL ( 3 patients )
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT ( 3 patients )
EPILEPSY ( 3 patients )
COAGULOPATHY ( 3 patients )
HEMIPARESIS ( 3 patients )
DIZZINESS ( 3 patients )
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ( 2 patients )
PHLEBITIS SUPERFICIAL ( 2 patients )
VARICOSE VEIN ( 2 patients )
CAROTID ARTERY DISEASE ( 2 patients )
MIGRAINE ( 2 patients )
CEREBRAL HAEMORRHAGE ( 2 patients )
BLOOD PRESSURE ( 2 patients )
SPEECH DISORDER ( 2 patients )
PAIN ( 2 patients )
CEREBRAL THROMBOSIS ( 2 patients )
PERIPHERAL ISCHAEMIA ( 2 patients )
ARTERY DISSECTION ( 2 patients )
VASCULAR CALCIFICATION ( 2 patients )
CONVULSION ( 2 patients )
CEREBELLAR INFARCTION ( 2 patients )
POST PROCEDURAL STROKE ( 2 patients )
ANGINA PECTORIS ( 2 patients )
HYPOAESTHESIA ( 2 patients )
BLOOD DISORDER ( 2 patients )
HYPOPERFUSION ( 2 patients )
OPTIC NERVE INFARCTION ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
ENZYME ABNORMALITY ( 2 patients )
ESSENTIAL THROMBOCYTHAEMIA ( 1 patients )
ARTERIAL STENOSIS ( 1 patients )
THYROID STIMULATING IMMUNOGLOBULIN ( 1 patients )
FEELING ABNORMAL ( 1 patients )
ARTHRITIS ( 1 patients )
CEREBROVASCULAR STENOSIS ( 1 patients )
HAEMODILUTION ( 1 patients )
ATRIAL FLUTTER ( 1 patients )
CONCUSSION ( 1 patients )
MEMORY IMPAIRMENT ( 1 patients )
VASCULAR DEMENTIA ( 1 patients )
PLATELET COUNT ( 1 patients )
AMNESIA ( 1 patients )
BALANCE DISORDER ( 1 patients )
VASCULITIS ( 1 patients )
CEREBRAL ARTERIOSCLEROSIS ( 1 patients )
BASAL GANGLION DEGENERATION ( 1 patients )
DIALYSIS ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
VERTIGO ( 1 patients )
OFF LABEL USE ( 1 patients )
AORTIC VALVE REPLACEMENT ( 1 patients )
HYPOTENSION ( 1 patients )
BRAIN STEM INFARCTION ( 1 patients )
EMBOLIC STROKE ( 1 patients )
ARRHYTHMIA ( 1 patients )
INFARCTION ( 1 patients )
THROMBOEMBOLIC STROKE ( 1 patients )
BRAIN STEM SYNDROME ( 1 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 1 patients )
ARTERIAL OCCLUSIVE DISEASE ( 1 patients )
ISCHAEMIA ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
EYE DISORDER ( 1 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 1 patients )
PLASMA VISCOSITY DECREASED ( 1 patients )
PLATELET AGGREGATION INHIBITION ( 1 patients )
AMAUROSIS FUGAX ( 1 patients )
ATRIAL SEPTAL DEFECT REPAIR ( 1 patients )
MICROANGIOPATHY ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
BASAL GANGLIA INFARCTION ( 1 patients )
DEEP VEIN THROMBOSIS ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
VASCULITIS CEREBRAL ( 1 patients )
CEREBRAL ATHEROSCLEROSIS ( 1 patients )
NERVOUS SYSTEM DISORDER ( 1 patients )
VISUAL IMPAIRMENT ( 1 patients )
ANXIETY ( 1 patients )
CEREBRAL HYPOPERFUSION ( 1 patients )
RUPTURED CEREBRAL ANEURYSM ( 1 patients )
BLOOD PRESSURE ABNORMAL ( 1 patients )
DYSARTHRIA ( 1 patients )
APHASIA ( 1 patients )
STENT PLACEMENT ( 1 patients )
BRAIN STEM ISCHAEMIA ( 1 patients )
PARAESTHESIA ( 1 patients )
INFLAMMATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with BRONCHITIS:

FOSAMAX (5575 patients)
VIOXX (3368 patients)
ASPIRIN (2369 patients)
ENBREL (1904 patients)
HUMIRA (1752 patients)
PREDNISONE (1569 patients)
ZOMETA (1537 patients)
SEROQUEL (1476 patients)
NEXIUM (1422 patients)
METHOTREXATE (1281 patients)
ALBUTEROL (1221 patients)
LASIX (1198 patients)
AREDIA (1138 patients)
TYSABRI (1123 patients)
LIPITOR (1083 patients)
PRILOSEC (1070 patients)
ADVAIR DISKUS 100/50 (1046 patients)
FORTEO (1017 patients)
SPIRIVA (945 patients)
SYNTHROID (915 patients)
NEURONTIN (906 patients)
LISINOPRIL (900 patients)
COUMADIN (896 patients)
ZOLOFT (866 patients)
AMBIEN (830 patients)
FOLIC ACID (823 patients)
REMICADE (810 patients)
PROTONIX (808 patients)
XANAX (787 patients)
LEVAQUIN (784 patients)
ZOCOR (766 patients)
SINGULAIR (759 patients)
CELEBREX (748 patients)
ACCUTANE (731 patients)
DIGOXIN (721 patients)
AVONEX (692 patients)
ATIVAN (691 patients)
FUROSEMIDE (690 patients)
TOPROL-XL (678 patients)
PREDNISOLONE (659 patients)
DEXAMETHASONE (646 patients)
PLAVIX (638 patients)
REVLIMID (623 patients)
XOLAIR (622 patients)
VICODIN (612 patients)
DECADRON (610 patients)
PREVACID (609 patients)
OMEPRAZOLE (603 patients)
POTASSIUM CHLORIDE (600 patients)
OXYCONTIN (596 patients)
LEXAPRO (586 patients)
PREDNISONE TAB (581 patients)
PERCOCET (578 patients)
ALENDRONATE SODIUM (576 patients)
ATENOLOL (572 patients)
HYDROCHLOROTHIAZIDE (567 patients)
PAXIL (567 patients)
LYRICA (566 patients)
NORVASC (566 patients)
ZITHROMAX (563 patients)
PREMARIN (559 patients)
IBUPROFEN (557 patients)
LORAZEPAM (541 patients)
ACETAMINOPHEN (534 patients)
DIOVAN (533 patients)
LEVOTHYROXINE SODIUM (519 patients)
SIMVASTATIN (519 patients)
VITAMIN D (512 patients)
SYMBICORT (509 patients)
CHANTIX (491 patients)
ZYRTEC (489 patients)
FLEXERIL (474 patients)
CYMBALTA (471 patients)
ZOFRAN (450 patients)
MULTI-VITAMINS (445 patients)
LORTAB (442 patients)
FOSAMAX PLUS D (441 patients)
PROZAC (431 patients)
GABAPENTIN (431 patients)
CELEXA (430 patients)
CRESTOR (426 patients)
CALCIUM (416 patients)
[THERAPY UNSPECIFIED] (411 patients)
DURAGESIC-100 (406 patients)
VITAMINS (UNSPECIFIED) (397 patients)
NITROGLYCERIN (393 patients)
WARFARIN SODIUM (389 patients)
CALCIUM (UNSPECIFIED) (387 patients)
ALLEGRA (386 patients)
KLONOPIN (383 patients)
AMOXICILLIN (376 patients)
ALLOPURINOL (376 patients)
LANTUS (376 patients)
OXYCODONE HCL (375 patients)
COMBIVENT (374 patients)
CHEMOTHERAPEUTICS NOS (371 patients)
ZYPREXA (370 patients)
METFORMIN HCL (367 patients)
THALIDOMIDE (364 patients)
COREG (363 patients)
TOCILIZUMAB (360 patients)
CLONAZEPAM (359 patients)
ZANTAC (356 patients)
HEPARIN SODIUM INJECTION (353 patients)
WELLBUTRIN (349 patients)
VELCADE (345 patients)
VALIUM (337 patients)
ACTONEL (336 patients)
VENTOLIN (331 patients)
METOPROLOL TARTRATE (331 patients)
NUVARING (330 patients)
REGLAN (329 patients)
VITAMIN E (328 patients)
NAPROXEN (327 patients)
LOPRESSOR (321 patients)
CLARITIN (314 patients)
TRAZODONE HCL (314 patients)
AVELOX (314 patients)
CLONIDINE (311 patients)
MORPHINE (306 patients)
ARANESP (301 patients)
LOVENOX (300 patients)
COLACE (297 patients)
DILAUDID (297 patients)
INSULIN (297 patients)
FLONASE (294 patients)
RISPERDAL (291 patients)
GLUCOPHAGE (290 patients)
FENTANYL (290 patients)
BONIVA (290 patients)
OXYGEN (289 patients)
FEMARA (288 patients)
EFFEXOR (288 patients)
MS CONTIN (283 patients)
COMPAZINE (280 patients)
ATROVENT (279 patients)
AZITHROMYCIN (279 patients)
TAXOTERE (278 patients)
CEPHALEXIN (276 patients)
ASCORBIC ACID (276 patients)
CIPROFLOXACIN (275 patients)
CARDIZEM (274 patients)
ULTRAM (269 patients)
KEFLEX (268 patients)
PEPCID (267 patients)
FLOVENT (266 patients)
TYLENOL (266 patients)
SPIRONOLACTONE (265 patients)
AUGMENTIN '125' (265 patients)
ALPRAZOLAM (263 patients)
DIFLUCAN (263 patients)
ELAVIL (262 patients)
MEDROL (261 patients)
MULTI-VITAMIN (260 patients)
CALCIUM CARBONATE (259 patients)
NYSTATIN (257 patients)
AMLODIPINE (256 patients)
TAMOXIFEN CITRATE (254 patients)
HYDROCODONE (254 patients)
CYTOXAN (253 patients)
ADRIAMYCIN PFS (250 patients)
SYNAGIS (250 patients)
TRAMADOL HCL (249 patients)
COZAAR (248 patients)
MORPHINE SULFATE (247 patients)
ACTEMRA (245 patients)
CLINDAMYCIN (244 patients)
DIAZEPAM (244 patients)
ACTOS (244 patients)
CIPRO (240 patients)
PLAQUENIL (238 patients)
KLOR-CON (238 patients)
BYETTA (237 patients)
ROCEPHIN (235 patients)
PROMETHAZINE (234 patients)
TYLENOL (CAPLET) (233 patients)
RANITIDINE (233 patients)
FAMOTIDINE (233 patients)
FLOMAX (232 patients)
NASONEX (231 patients)
MUCINEX (230 patients)
ARIMIDEX (227 patients)
METOCLOPRAMIDE (227 patients)
VERAPAMIL (224 patients)
BENADRYL (222 patients)
FISH OIL (222 patients)
AVANDIA (220 patients)
BEXTRA (219 patients)
VITAMIN B-12 (218 patients)
MOTRIN (218 patients)
DOXYCYCLINE (218 patients)
SOMA (217 patients)
ACYCLOVIR (217 patients)
TRACLEER (215 patients)
FLUCONAZOLE (214 patients)
TEMAZEPAM (214 patients)
METOPROLOL (213 patients)
ACIPHEX (210 patients)
HEPARIN (209 patients)
SEROQUEL XR (206 patients)
AMITRIPTYLINE HCL (206 patients)
LANSOPRAZOLE (205 patients)
GLIPIZIDE (205 patients)
SANDOSTATIN LAR (204 patients)
ALTACE (204 patients)
PULMICORT (202 patients)
RADIATION THERAPY (202 patients)
DARVOCET-N 100 (202 patients)
PANTOPRAZOLE (199 patients)
ALDACTONE (199 patients)
Most common side effects for patients taking AGGRENOX:
HEADACHE (532 patients)
CEREBROVASCULAR ACCIDENT (466 patients)
NAUSEA (408 patients)
DIZZINESS (303 patients)
TRANSIENT ISCHAEMIC ATTACK (267 patients)
VOMITING (254 patients)
ASTHENIA (240 patients)
DIARRHOEA (234 patients)
FATIGUE (182 patients)
PAIN (176 patients)
FALL (170 patients)
PAIN IN EXTREMITY (149 patients)
DYSPNOEA (144 patients)
ANAEMIA (134 patients)
CHEST PAIN (130 patients)
RENAL FAILURE ACUTE (124 patients)
OEDEMA PERIPHERAL (122 patients)
ANXIETY (121 patients)
DEPRESSION (118 patients)
ABDOMINAL PAIN UPPER (113 patients)
HYPOAESTHESIA (112 patients)
HYPERTENSION (110 patients)
HYPOTENSION (105 patients)
MALAISE (104 patients)
CONFUSIONAL STATE (103 patients)
URINARY TRACT INFECTION (99 patients)
RENAL FAILURE (98 patients)
BACK PAIN (98 patients)
PNEUMONIA (96 patients)
WEIGHT DECREASED (95 patients)
ARTHRALGIA (94 patients)
GAIT DISTURBANCE (94 patients)
MYOCARDIAL INFARCTION (89 patients)
PYREXIA (89 patients)
DEHYDRATION (85 patients)
DRUG INEFFECTIVE (83 patients)
COUGH (83 patients)
MYALGIA (79 patients)
ATRIAL FIBRILLATION (79 patients)
CONVULSION (77 patients)
MUSCULAR WEAKNESS (77 patients)
DYSPHAGIA (76 patients)
LOSS OF CONSCIOUSNESS (76 patients)
PRURITUS (73 patients)
SOMNOLENCE (72 patients)
CONSTIPATION (72 patients)
CEREBRAL HAEMORRHAGE (72 patients)
FEELING ABNORMAL (72 patients)
INSOMNIA (71 patients)
ABDOMINAL PAIN (68 patients)
GASTROINTESTINAL HAEMORRHAGE (68 patients)
DECREASED APPETITE (67 patients)
RASH (67 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (66 patients)
HAEMORRHAGE (65 patients)
BLOOD PRESSURE INCREASED (65 patients)
DEATH (62 patients)
DYSPEPSIA (60 patients)
INJURY (59 patients)
BLOOD GLUCOSE INCREASED (59 patients)
SYNCOPE (59 patients)
ABDOMINAL DISCOMFORT (58 patients)
CEREBRAL INFARCTION (57 patients)
VISION BLURRED (57 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (57 patients)
HEMIPARESIS (56 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (56 patients)
RESPIRATORY FAILURE (55 patients)
MUSCLE SPASMS (54 patients)
CONTUSION (54 patients)
MEMORY IMPAIRMENT (54 patients)
NEUROPATHY PERIPHERAL (54 patients)
CARDIAC DISORDER (54 patients)
FLUSHING (53 patients)
HAEMOGLOBIN DECREASED (53 patients)
GASTRITIS (53 patients)
PARAESTHESIA (53 patients)
PALPITATIONS (52 patients)
SINUSITIS (50 patients)
RENAL FAILURE CHRONIC (50 patients)
DYSARTHRIA (50 patients)
EPISTAXIS (49 patients)
HYPERHIDROSIS (48 patients)
CARDIAC FAILURE CONGESTIVE (48 patients)
THROMBOCYTOPENIA (46 patients)
TREMOR (45 patients)
DYSGEUSIA (44 patients)
BALANCE DISORDER (44 patients)
CATARACT (43 patients)
SEPSIS (43 patients)
APHASIA (42 patients)
CORONARY ARTERY DISEASE (41 patients)
DEMENTIA (41 patients)
ABDOMINAL DISTENSION (40 patients)
SPEECH DISORDER (40 patients)
CONDITION AGGRAVATED (40 patients)
DIABETES MELLITUS (40 patients)
OFF LABEL USE (40 patients)
RETCHING (39 patients)
NECK PAIN (39 patients)
BLOOD PRESSURE DECREASED (39 patients)
WEIGHT INCREASED (38 patients)
BLOOD CHOLESTEROL INCREASED (38 patients)
ARTERIOSCLEROSIS (38 patients)
OSTEONECROSIS OF JAW (38 patients)
ATELECTASIS (38 patients)
EMOTIONAL DISTRESS (37 patients)
DIVERTICULUM (37 patients)
DYSPNOEA EXERTIONAL (37 patients)
DUODENAL ULCER (37 patients)
RECTAL HAEMORRHAGE (36 patients)
OSTEOPENIA (36 patients)
DEEP VEIN THROMBOSIS (36 patients)
RIB FRACTURE (36 patients)
CHEST DISCOMFORT (36 patients)
ANHEDONIA (35 patients)
URINARY INCONTINENCE (35 patients)
ABASIA (33 patients)
BLOOD CREATININE INCREASED (33 patients)
HYPERSENSITIVITY (33 patients)
ACUTE MYOCARDIAL INFARCTION (32 patients)
LUNG NEOPLASM MALIGNANT (32 patients)
VERTIGO (32 patients)
CARDIAC ARREST (32 patients)
HYPERLIPIDAEMIA (32 patients)
ERYTHEMA (31 patients)
MENTAL STATUS CHANGES (31 patients)
ISCHAEMIC STROKE (31 patients)
COLONIC POLYP (31 patients)
CAROTID ARTERY STENOSIS (31 patients)
TOOTHACHE (31 patients)
MUSCULOSKELETAL STIFFNESS (31 patients)
OVERDOSE (31 patients)
DYSPHONIA (31 patients)
TOOTH DISORDER (30 patients)
BLINDNESS (30 patients)
NIGHT SWEATS (30 patients)
AGEUSIA (29 patients)
LETHARGY (29 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (29 patients)
INFECTION (29 patients)
HAEMORRHOIDS (29 patients)
BRONCHITIS (29 patients)
URINARY RETENTION (29 patients)
DRY MOUTH (28 patients)
HAEMATURIA (28 patients)
HERPES ZOSTER (28 patients)
CYST (28 patients)
HYPOGLYCAEMIA (28 patients)
HALLUCINATION (28 patients)
HEAD INJURY (28 patients)
NEPHROLITHIASIS (28 patients)
RENAL CYST (28 patients)
EMPHYSEMA (27 patients)
HAEMATOMA (27 patients)
DISORIENTATION (27 patients)
THROMBOSIS (27 patients)
AMNESIA (27 patients)
FOOT FRACTURE (27 patients)
ANOREXIA (27 patients)
PLATELET COUNT DECREASED (27 patients)
INTERVERTEBRAL DISC DEGENERATION (27 patients)
GASTRITIS EROSIVE (27 patients)
CHILLS (27 patients)
ROTATOR CUFF SYNDROME (26 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (26 patients)
WHEEZING (26 patients)
HIP FRACTURE (26 patients)
DRUG INTERACTION (26 patients)
VISUAL IMPAIRMENT (26 patients)
FAECAL INCONTINENCE (25 patients)
SUBDURAL HAEMATOMA (25 patients)
CARDIOMEGALY (25 patients)
INCORRECT DOSE ADMINISTERED (25 patients)
CARDIO-RESPIRATORY ARREST (25 patients)
ORTHOSTATIC HYPOTENSION (25 patients)
CAROTID ARTERY OCCLUSION (25 patients)
BONE PAIN (25 patients)
MITRAL VALVE INCOMPETENCE (25 patients)
OSTEOARTHRITIS (25 patients)
HYPOKALAEMIA (25 patients)
HOT FLUSH (24 patients)
IRRITABLE BOWEL SYNDROME (24 patients)
PULMONARY FIBROSIS (24 patients)
SKIN TIGHTNESS (24 patients)
NOCTURIA (24 patients)
HYPERKALAEMIA (24 patients)
UNRESPONSIVE TO STIMULI (24 patients)
PLEURAL EFFUSION (24 patients)
OSTEOPOROSIS (24 patients)
HEART RATE INCREASED (24 patients)
JOINT SWELLING (24 patients)
TINNITUS (24 patients)
INFLUENZA LIKE ILLNESS (24 patients)
MIGRAINE (24 patients)
METABOLIC ACIDOSIS (23 patients)
RASH GENERALISED (23 patients)
ALANINE AMINOTRANSFERASE INCREASED (23 patients)
ALOPECIA (23 patients)
TACHYCARDIA (23 patients)
OESOPHAGITIS (23 patients)
INFLUENZA (23 patients)
HAEMATEMESIS (23 patients)
SPINAL OSTEOARTHRITIS (23 patients)
HYPERCALCAEMIA (23 patients)
COMA (23 patients)
CEREBRAL ATROPHY (23 patients)
SINUS BRADYCARDIA (23 patients)
AGITATION (22 patients)
TIBIA FRACTURE (22 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AGGRENOX


Issue Description / Topic Timestamp
QUESTION
NEUROPATHY
I am a 76 yr old female and take Aggrenox. Lately I have noticed numbness on the soles of both feet and above one knee to buttock and am trying to determine the cause. My doctor is guessing two pinched spinal nerves and has sent me to physical therapist. I've not noticed a change thus far and am trying to do my own sleuthing. Has anyone else had this reaction to the drug? 2014-11-21 20:22:34
QUESTION
MACULAR DEGENERATION
I've being taking aggrenox for a few years and although i'd recently was diagnosed with macular distrophy, i did not think aggrenox as a probable cause but on the other hand the Dr that diagnosed me told me that since there was no family history nor other facts like look at an eclipse directly etc he found no cause at so early age im 47, my question is, could be my problem a correlated cause of using this medicine, aggrenox? 2014-11-24 19:06:28
QUESTION
MACROGLOSSIA
I began taking Aggrenox Jan 2014. In approx June 2015 I was diagnosed with macroglossia - tongue swelling. Any chance it is caused by Aggrenox? I have been tested for allergies that was negative. Tongue is pushing on front teeth in sleep moving upper jaw significantly. Help! 2015-12-04 17:51:00
QUESTION
BURNING SENSATION
headackes and burning sensation over most of body. Can this be caused by taking Aggrenox? 2016-02-08 19:59:22
QUESTION
DRY MOUTH
Can aggrenox cause dry mouth? 2016-07-31 20:15:08

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about BRONCHITIS and AGGRENOX, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AGGRENOX, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AGGRENOX. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AGGRENOX experts. If you are a healthcare provider experienced in prescribing AGGRENOX, please register here.

Your online appointment book for Ypsilanti Rentals & Services

Chef and Catering services in Ypsilanti
Chiropracter and Massage services in Ypsilanti
Event and Wedding Planning services in Ypsilanti
Hair Styling services in Ypsilanti
Personal Shopping services in Ypsilanti
Photography and Videography services in Ypsilanti
Private Investigation services in Ypsilanti
Website Design services in Ypsilanti

Home
Appliance Repair services in Ypsilanti
Appraisals services in Ypsilanti
Awnings services in Ypsilanti
Builder Services services in Ypsilanti
Carpentry services in Ypsilanti
Cleaning services in Ypsilanti
Decks and Porches services in Ypsilanti
Electricians services in Ypsilanti
Fireplace services in Ypsilanti
Generators services in Ypsilanti
Greenhouses and Nurseries services in Ypsilanti
Handymen services in Ypsilanti
Home Security services in Ypsilanti
HVAC services in Ypsilanti
Insulation services in Ypsilanti
Interior Design services in Ypsilanti
Landscaping services in Ypsilanti
Lawn and Yard services in Ypsilanti
Locksmiths services in Ypsilanti
Marble and Granite Experts services in Ypsilanti
Masonry services in Ypsilanti
Moving Services services in Ypsilanti
Painters services in Ypsilanti
Plumbing services in Ypsilanti
Pool and Spa services in Ypsilanti
Property Management services in Ypsilanti
Roofers services in Ypsilanti
Snow Plowing services in Ypsilanti
Solar Power Consultants services in Ypsilanti
Upholstery services in Ypsilanti
Wallpaper services in Ypsilanti
Waterproofing services in Ypsilanti
Windows services in Ypsilanti
Services - Other

© 2014 FactMed, Inc
Privacy Policy
Terms of Use